Until now, patients have had to spend hours on a drip to get the drug pembrolizumab (Keytruda) to treat their cancer.
Notifications can be managed in browser preferences.
Swipe for next article
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Tens of thousands of patients could benefit from a one-minute jab being rolled out on the NHS for more than a dozen cancers.
Injectable pembrolizumab can treat several types of cancer and can be administered in under two minutes
The jab uses mRNA technology to train the immune system to fight cancerous cells
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
One early adopter describes how he was in remission ‘within the first two or three weeks’ after the treatment
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine
Men with high-risk prostate cancer that has not yet spread now qualify for the treatment
